A Multi-Component Weight Loss Intervention to Improve Outcomes of Total Knee Replacement

Sponsor
University of Kansas Medical Center (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05853497
Collaborator
South Dakota State University (Other)
30
2
18.1

Study Details

Study Description

Brief Summary

Obesity, specifically BMIs ≥35 or 40 kg/m2, are associated with an increased probability of poor outcomes of Total Knee Arthroplasty (TKA) including increased pain, risk for infection, poor joint function, and increased rates of hospital readmissions. Several orthopedic and public health organizations recommend weight loss prior to TJA for individuals with overweight/obesity. However, empirical evidence suggesting the effectiveness of pre-surgical weight loss on surgical and functional outcomes of TKA is extremely limited and is based primarily on non-randomized observational studies. Thus, to gain further insight regarding the feasibility and potential effectiveness of pre-surgical weight loss on outcomes of TKA, the proposed pilot trial will randomize 30 patients (age 50-75 yrs., BMI 35<40 kg/m2) scheduled for TKA through The University of Kansas Health System Department of Orthopedics and Sports Medicine (KUOrtho) to a multi-component weight loss (3-mo. pre-TKA, very low-calorie diet) and maintenance intervention (3-mo. post TKA, conventional maintenance diet) or standard care control which will include no dietary or weight loss advice. The weight loss/maintenance interventions will include reduced energy intake or energy intake prescribed for weight loss maintenance, increased physical activity, and individual behavior counseling. Outcomes will be assessed 1) baseline, i.e., 3 mos. prior to surgery, 2) 3 mos. i.e., at the completion of the weight loss intervention prior to TKA, 3) within a minimum of 2 weeks post TKA, and 4) 3 mos. post-TKA, i.e., after completion of the weight maintenance intervention to assess the feasibility and effectiveness of a remotely delivered multi-component pre-TKA weight loss and a post-TKA weight maintenance intervention.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Multi-Component Weight Loss Intervention
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Care Provider, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
A Multi-Component Weight Loss Intervention to Improve Outcomes of Total Knee Replacement
Anticipated Study Start Date :
May 1, 2023
Anticipated Primary Completion Date :
Jul 1, 2024
Anticipated Study Completion Date :
Nov 1, 2024

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Standard Care Control

Standard care

Experimental: Intervention

Multi-component weight loss intervention

Behavioral: Multi-Component Weight Loss Intervention
The intervention group will receive weekly 1-on-1 health coaching with a very-low calorie nutrition plan prior to total knee replacement and a conventional weight maintenance nutrition plan after surgery.

Outcome Measures

Primary Outcome Measures

  1. Participant Retention Feasibility [6 Months]

    Feasibility will be based on retention of ≥ 80% participants (i.e., <20% participant dropout).

  2. Participant Attendance Feasibility [6 Months]

    Feasibility will be based on ≥ 80% attendance at behavioral counseling sessions.

Secondary Outcome Measures

  1. Knee and Lower Extremity Physical Function (OARSI Test) [6 Months]

    Knee and lower extremity function will be compared between study arms using the Osteoarthritis Research Society International (OARSI) physical function test battery.

  2. Fat Mass (kg) [6 Months]

    Changes in fat mass (kg) will be compared between study arms using dual x-ray absorptiometry (DEXA)

  3. Fat Free Mass (kg) [6 Months]

    Changes in fat free mass (kg) will be compared between study arms using dual x-ray absorptiometry (DEXA)

  4. Body Weight (kg) [6 Months]

    Changes in body weight (kg) will be compared between study arms using a calibrated body weight scale.

  5. Self reported knee function [6 Months]

    Self-reported knee function will be compared between study arms using the Knee Injury and Osteoarthritis Outcome Score (KOOS) questionnaire. Scores range from 0 to 100 with a score of 0 indicating the worst possible knee symptoms and 100 indicating no knee symptoms.

Eligibility Criteria

Criteria

Ages Eligible for Study:
50 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age: 50-75 years

  • BMI: 35 to ≤40 kg/m2

  • Patient of KU Health System Department of Orthopedics and Sports Medicine (KUOrtho)meeting all requirements for TKA surgery.

  • TKA surgical date scheduled ≥3 mos. from consent

  • Own a Bluetooth enabled computer, tablet, or smart phone with the ability to join remote telehealth sessions and sync study self-monitoring devices.

Exclusion Criteria:
  • Weight loss ≥10 pounds in previous 6 months

  • Dairy/milk protein allergy

  • Currently pregnant/breastfeeding or planning to become pregnant during the study

  • Currently being treated for an eating disorder or history of an eating disorder diagnosis

  • Pacemaker

  • Current Cancer

  • Diabetes Type 1 (insulin dependent)

  • Hyperuricemia (untreated)

  • Inflammatory bowel disease (active)

  • Liver disease requiring protein restriction

  • Myocardial infarction within last 3 months

  • Abnormal ECG

  • Renal insufficiency.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • University of Kansas Medical Center
  • South Dakota State University

Investigators

  • Principal Investigator: Steve Herrmann, PhD, University of Kansas Medical Center

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Kansas Medical Center
ClinicalTrials.gov Identifier:
NCT05853497
Other Study ID Numbers:
  • STUDY00149595
First Posted:
May 10, 2023
Last Update Posted:
May 10, 2023
Last Verified:
May 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University of Kansas Medical Center
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 10, 2023